CareFusion recalls faulty ventilators; Pakistan lab may not be testing all drugs; TSA agent nailed for turning blind eye to oxycodone;

> CareFusion is voluntarily recalling some of its AirLife Infant Breathing Circuit closed ventilation systems because tubes can crack and affect the volume delivered. FDA announcement

> RSSL says it is now offering a service that will use scanners to track contamination at pharmaceutical manufacturing plants. Story

>The U.S. is threatening to take India before a World Trade Organization panel for handing over to a generic drugmaker there the country's first compulsory license for Bayer's cancer drug Nexavar. Article

> Contract manufacturing organizations CMOs are taking on strategic partnerships and new capabilities to expand their reach. Story

> Pakistan's lead government lab that is supposed to be testing drugs in Pakistan for quality, but lacks funding and experienced technicians, and may not be checking all of the drugs under its authority. Story

And Finally... A former TSA agent is expected to be sentenced later this month for taking bribes to allow a drug courier walk through the West Palm Beach, FL, airport carrying up to 8,000 oxycodone pills a trip. Story
 

Suggested Articles

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.

AstraZeneca has signed a $750 million deal to produce up to 300 million doses of Oxford University's COVID-19 vaccine by year's end.

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot.